Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis
Laura Calvo‐Barreiro(Cornell University), Carmen Espejo(Universitat Autònoma de Barcelona)
Cited by 42
Related Papers
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
|Brain|2020|136
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis
|Autoimmunity Reviews|2017|95
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
|Autoimmunity Reviews|2021|94